Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial
Crossref DOI link: https://doi.org/10.1186/s12955-017-0704-y
Published Online: 2017-06-23
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Devlin, Nancy
Herdman, Michael
Pavesi, Marco
Phung, De
Naidoo, Shevani
Beer, Tomasz M.
Tombal, Bertrand
Loriot, Yohann
Ivanescu, Cristina
Parli, Teresa
Balk, Mark
Holmstrom, Stefan
Funding for this research was provided by:
Astellas Pharma US
Medivation